论文部分内容阅读
目的分析比较早期非小细胞肺癌肺段切除与肺叶切除手术的疗效。方法回顾性分析2009年1月~2010年1月于我院住院治疗的90例非小细胞肺癌患者的生存率及临床疗效。结果肺段切除术的闭式引流时间、肺不张、心衰、血胸比例较肺叶切除术相比具有较好的临床表现,并进行4年的跟踪随访,接受VATS肺段切除术的患者无病生存的比例为89.9%,接受VATS肺叶切除术的患者的无病生存的比例为86.7%。结论 VATS肺段切除术在对Ⅰa期非小细胞肺癌患者治疗中,有较好的安全性和有效性,肺段切除术组与肺叶切除术组的患者生存率差异不大。
Objective To analyze the curative effect of segmentectomy and lobectomy in the early stage of non-small cell lung cancer. Methods Retrospective analysis of 90 cases of non-small cell lung cancer patients hospitalized in our hospital from January 2009 to January 2010 survival rate and clinical efficacy. Results The closed drainage time, atelectasis, heart failure and hemothoracic resection of segmentectomy had better clinical performance than lobectomy, and were followed up for 4 years. Patients undergoing VATS segmentectomy The proportion of disease-free survival was 89.9%, and the proportion of disease-free survival in patients undergoing VATS lobectomy was 86.7%. Conclusions VATS segmentectomy is safe and effective in the treatment of patients with stage Ⅰa non-small cell lung cancer. There is no significant difference in the survival rates between patients in segmentectomy group and lobectomy group.